Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations

ABSTRACT: Targeted next-generation sequencing was performed in patients with IDH2-mutant acute myeloid leukemia to identify genomic mechanisms of primary or acquired resistance to the mutant IDH2 inhibitor enasidenib.

INSTRUMENT(S): -

ORGANISM(S): Homo Sapiens

SUBMITTER: Memorial Sloan Kettering Cancer Center

PROVIDER: PRJEB26337 | EVA | 2018-04-20

REPOSITORIES: EVA

ACCESS DATA

Json Xml

Similar Datasets

E-GEOD-69556

Project description:Next Generation Sequencing of PKD2 mutant mice kidneys

2019-05-14 | E-GEOD-69556 | ExpressionAtlas

E-GEOD-118498

Project description:Next Generation Sequencing Facilitates Quantitative Analysis of WT and dek42 mutant Transcriptomes

2020-04-06 | E-GEOD-118498 | ExpressionAtlas

E-GEOD-113048

Project description:Next Generation Sequencing Facilitates Quantitative Analysis of WT and zmbzip22 mutant Transcriptomes

2020-04-06 | E-GEOD-113048 | ExpressionAtlas

E-GEOD-97422

Project description:Next Generation Sequencing Facilitates Quantitative Analysis of WT and o11 mutant Transcriptomes

2020-04-06 | E-GEOD-97422 | ExpressionAtlas

E-GEOD-120674

Project description:Next Generation Sequencing Facilitates Quantitative Analysis of WT and dek15 mutant Transcriptomes

2020-04-06 | E-GEOD-120674 | ExpressionAtlas

E-GEOD-60424

Project description:Next generation sequencing of human immune cell subsets across diseases

2025-01-24 | E-GEOD-60424 | ExpressionAtlas

Dynamic induction of drug resistance through a stress-responsive enhancer in acute myeloid leukemia [CHIP-seq]

Project description:The drug efflux pump ABCB1 is a key driver of chemoresistance, and high expression predicts for treatment failure in acute myeloid leukemia (AML). We show that both acute and chronic exposure of leukemia cells to daunorubicin activates an integrated stress response-like transcriptional program to induce ABCB1 through remodeling and dynamic activation of an ATF4-bound, stress-responsive enhancer. In primary human AML, stress-responsive ABCB1 enhancers are accessible and acetylated, and exposure of fresh blast cells to daunorubicin induces ABCB1 in a dose-dependent manner. Dynamic induction of ABCB1 by diverse stressors, including chemotherapy, facilitates escape of leukemia cells from targeted third-generation ABCB1 inhibition. Stress-induced up regulation of ABCB1 is mitigated by combined use of pharmacologic inhibitors U0126 and ISRIB, which inhibit stress signaling.

2020-02-03 | GSE131824 | GEO

Dynamic induction of drug resistance through a stress-responsive enhancer in acute myeloid leukemia [RNA-seq]

2020-02-03 | GSE131823 | GEO

ASXL1 Mutations Promote Myeloid Transformation Through Loss of PRC2-Mediated Gene Repression

Project description:Recurrent somatic ASXL1 mutations occur in patients with myelodysplasia (MDS), myeloproliferative neoplasms (MPN), and acute myeloid leukemia (AML), and are associated with adverse outcome. Despite the genetic and clinical data implicating ASXL1 mutations in myeloid malignancies, the mechanisms of transformation by ASXL1 mutations are not understood. Here we identify that ASXL1 mutations result in loss of PRC2-mediated histone H3 lysine 27 (H3K27) tri-methylation. Through integration of microarray data with genome-wide histone modification ChIP-Seq data we identify targets of ASXL1 repression including the posterior HOXA cluster that is known to contribute to myeloid transformation. We demonstrate that ASXL1 associates with the Polycomb repressive complex 2 (PRC2), and that loss of ASXL1 in vivo collaborates with NRASG12D to promote myeloid leukemogenesis. To assess the genome-wide effects of ASXL1 loss on chromatin state we performed chromatin immunoprecipitation followed by next generation sequencing (CHIP-seq) for histone modifications known to be associated with PcG (histone H3 lysine 27 trimethylation (H3K27me3)) or TxG activity (histone H3 lysine 4 trimethylation (H3K4me3)) in UKE1 cells expressing empty vector (EV) or 2 independent validated shRNAs for ASXL1. This Series represents the ChIP-Seq data (not the microarray data referenced in the summary above). The related micorarray data are available in GEO as GSE38692.

2012-08-21 | E-GEOD-38861 | biostudies-arrayexpress

Genomic profiling of the FaDu cell line and derived subclones using amplicon-based targeted sequencing

Project description:Mutational profiling by targeted next-generation sequencing of a SCCHN cell line model and single-cell derived subclones displaying varying sensitivity to cisplatin was used to determine the extent of intratumoral heterogeneity and to dissect the molecular mechanisms involved in primary cisplatin resistance and treatment-induced clonal evolution.

2017-12-04 | E-MTAB-6021 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data